BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34088002)

  • 1. Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the London mutation in APP (V717I).
    Hernández D; Morgan Schlicht S; Daniszewski M; Karch CM; ; Goate AM; Pébay A
    Stem Cell Res; 2021 May; 53():102373. PubMed ID: 34088002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I).
    Grigor'eva EV; Malankhanova TB; Ustyantseva EI; Minina JM; Redina OE; Morozov VV; Shevela AI; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Apr; 36():101415. PubMed ID: 30851551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene.
    Oksanen M; Hyötyläinen I; Voutilainen J; Puttonen KA; Hämäläinen RH; Graff C; Lehtonen Š; Koistinaho J
    Stem Cell Res; 2018 Aug; 31():181-185. PubMed ID: 30099334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
    Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
    Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation.
    Sun W; Wang P; Gong J; Chen Y; Yang Y; Luan H; Li S; Li R; Wei C
    Stem Cell Res; 2023 Sep; 71():103149. PubMed ID: 37356183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
    Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
    Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
    Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
    Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an induced pluripotent stem cell line from a patient with global development delay carrying DYRK1A mutation (c.1730T>A) and a gene correction isogenic iPSC line.
    Ma L; Wu Z; Tang Q; Ji X; Mei Y; Peng T; Xu Q; Zhou W; Xiong M
    Stem Cell Res; 2021 May; 53():102305. PubMed ID: 33813175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of a human induced pluripotent stem cell line (XWHNi001-A) derived from an Alzheimer's disease patient with mutation in the APP gene.
    Wei C; Lu X; Zou Q; Gong S; Chen Y; Lyu J; Jia J
    Stem Cell Res; 2022 Apr; 60():102690. PubMed ID: 35149456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
    Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
    Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation.
    Wang Y; Zhang J; Hu J; Li G; Lei Y; Zhao J
    Stem Cell Res; 2019 Apr; 36():101391. PubMed ID: 30831521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
    Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
    Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
    Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing.
    Lilianty J; Bateman JF; Lamandé SR
    Stem Cell Res; 2021 Oct; 56():102515. PubMed ID: 34543885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a human induced pluripotent stem cell (iPSC) line from skin fibroblasts of a patient carrying an E363Q mutation in PSEN1 gene.
    Zhu W; Zhou Y; Wang Q; Li J; Chu S; Jin W; Mao C; Dong L; Gao J; Xu Q
    Stem Cell Res; 2022 May; 61():102769. PubMed ID: 35421846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of six human iPSC lines from patients with a familial Alzheimer's disease (n = 3) and sex- and age-matched healthy controls (n = 3).
    Raska J; Hribkova H; Klimova H; Fedorova V; Barak M; Barta T; Pospisilova V; Vochyanova S; Vanova T; Bohaciakova D
    Stem Cell Res; 2021 May; 53():102379. PubMed ID: 34088008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of an iPS cell line (PUMCi006-A) from skin fibroblasts of a patient with an M239T mutation in PSEN2 gene.
    Zhu W; Zhou J; Shang L; Zhou Y; Wang Q; Yu Y; Dong L; Mao C; Chu S; Jin W; Li J; Gao J
    Stem Cell Res; 2024 Jun; 77():103391. PubMed ID: 38531230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene.
    Frederiksen HR; Holst B; Ramakrishna S; Muddashetty R; Schmid B; Freude K
    Stem Cell Res; 2019 Jan; 34():101368. PubMed ID: 30634129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.